lenalidomide has been researched along with Hemophilia A in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, BL; Lin, ZY; Sun, JJ; Wang, YF; Wu, X; Xiao, X; Zhang, FX; Zhou, XY | 1 |
| Andres, M; Angelillo-Scherrer, A; Dickenmann, M; Jalowiec, KA; Kremer Hovinga, JA; Musa, A; Rovó, A; Taleghani, BM | 1 |
| Kaiser, T; Metze, M; Petros, S; Pfrepper, C; Pierer, M; Poenisch, W | 1 |
| Ikebe, T; Itani, K; Miyazaki, Y; Nagamatsu, K; Ogata, M; Ohtsuka, E; Saburi, M; Saburi, Y | 1 |
1 review(s) available for lenalidomide and Hemophilia A
| Article | Year |
|---|---|
Acquired hemophilia A and plasma cell neoplasms: a case report and review of the literature.
Topics: Aged; Factor VIII; Hemophilia A; Humans; Lenalidomide; Male; Multiple Myeloma; Plasmacytoma; Thalidomide | 2020 |
3 other study(ies) available for lenalidomide and Hemophilia A
| Article | Year |
|---|---|
[Study on the Therapeutic Effect of Lenalidomide on Hemophilic Arthropathy].
Topics: Animals; Arthritis; Cytokines; Hemarthrosis; Hemophilia A; Humans; Interleukin-6; Lenalidomide; Mice; Neovascularization, Pathologic; RNA, Messenger; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2022 |
Inhibitor eradication in refractory acquired hemophilia with lenalidomide.
Topics: Autoantibodies; Autoimmune Diseases; Drug Eruptions; Drug Substitution; Factor VIII; Hemophilia A; Hemorrhage; Humans; Immunosuppressive Agents; Lenalidomide; Male; Middle Aged; Paraplegia; Spinal Cord | 2019 |
Development of acquired hemophilia A during treatment of multiple myeloma with lenalidomide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Hemophilia A; Humans; Lenalidomide; Multiple Myeloma; Thalidomide | 2015 |